high-dose Group ACYW135X Meningococcal Conjugate Vaccine
PRO-ACYWX-1001
Phase 1 mab active
Quick answer
high-dose Group ACYW135X Meningococcal Conjugate Vaccine for Meningococcal Meningitis is a Phase 1 program (mab) at SINOVAC BIOTECH LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SINOVAC BIOTECH LTD
- Indication
- Meningococcal Meningitis
- Phase
- Phase 1
- Modality
- mab
- Status
- active